Smith & Nephew Share Discussion Threads

[hubshank] 01/4/2021 12:04

My local paper has just run an article saying more than 2,200 covid patients discharged and now focussing on procedure wiating list.

London will be doing the same as I saw article other day saying no new cases in London.

[its the oxman] 01/4/2021 09:52

Added as well. Poor sentiment and expected newsflow very much in the price. Any slight expectation of a pick up or bid and we could be 20% higher quite quickly. Hopefully the downside is limited.

[timbo_slice] 31/3/2021 22:08

Welcome aboard.

[justiceforthemany] 31/3/2021 18:36

Bought in. Elective surgery should surge during the summer. Can see this returning to the 1600-1700p range.

[ianood] 10/3/2021 18:01

Susceptible to a bid from Stryker I think!

[spoole5] 10/3/2021 12:14

Yep, great industry to be in, will hugely benefit from an aging population

[its the oxman] 10/3/2021 10:22

Depressed by covid, fundamental value remains and agree a bid is more likely than ever.

[spoole5] 03/3/2021 14:51

Will be vulnerable to a bid soon at these levels

[essentialinvestor] 03/3/2021 14:40

Pricy still.

[essentialinvestor] 02/3/2021 15:10

Good to see clarification of the multiples I posted last week.


As someone mentioned to me who disputed the figures

...perhaps it's about the quality of your information.


Yes, perhaps it is.

[philanderer] 02/3/2021 13:25

Questor: Smith & Nephew may have grazed its knees with Covid, but it has plenty of fight left

Questor share tip: cancelled surgeries have reduced the need for medical supplies, but demand could well bounce back after lockdown

Smith & Nephew could deliver some pleasant surprises in 2021 and beyond. Hold.

Questor says: hold

[piano man] 25/2/2021 13:56

With defensive qualities 30% in 2 years will do me.

[spoole5] 23/2/2021 16:37

Unlikely to take 2 years

[essentialinvestor] 23/2/2021 16:31

My Dad uses professional data, will check with him but he's not
available atm.

To make USD1.85, that's an 80% increase on FY 2019,
I can't square that number with anything I've looked at.

The 2019 FY is pre Covid-19 earnings.

[gclark] 23/2/2021 16:24

My source gives a consensus forecast PE of US$1.85, approx £1.30, so around 11 times at £14.

[essentialinvestor] 23/2/2021 16:23

That's peak pre Covid-19 earnings.

You are looking at a 2 year recovery to get back to that?.

[spoole5] 23/2/2021 16:21

Just under 20 not overly expensive given the significant growth opportunities

[essentialinvestor] 23/2/2021 16:17

Well I'm looking at the adjusted EPS for 2019 at $1.02 (which allows for any (exceptionals).
year ending 31/12/2019 - pre Covid-19 hitting.

On current FX that gives a PE of just under 20 X.


How are you getting 10 X earnings.

[gclark] 23/2/2021 16:11

I see it on a forward forecast PE for 2021 of 10, at a share price of £14, which is not steep.

It seems like a decent source of information but we are all limited by our information source!

[essentialinvestor] 23/2/2021 13:53

spoole, I've looked at FY 2018 EPS, which was the recent peak and flattered

by a legal settlement and still get what appears a pricy multiple.

As SN report in USD, you need to convert earnings in to GBP to calculate.

[spoole5] 23/2/2021 13:48

I don't think anyone can accurately predict any earnings for companies hit by covid.

[essentialinvestor] 23/2/2021 13:30

* 24 X FY 2022 earnings estimates, I've not got FY 2023 numbers.

[essentialinvestor] 23/2/2021 13:28

spoole, have you looked at '22, '23 estimates?.

SN still looks on a steep multiple if I'm reading those correctly.

[spoole5] 23/2/2021 08:30

Amazing how the market is pricing in a recovery for airlines and pubs but not for this